Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4101782
Max Phase: Preclinical
Molecular Formula: C23H37N5O2
Molecular Weight: 415.58
Molecule Type: Small molecule
Associated Items:
ID: ALA4101782
Max Phase: Preclinical
Molecular Formula: C23H37N5O2
Molecular Weight: 415.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCN(CCC)c1nc(NC2CCN(C)CC2)c2cc(OC)c(OC)cc2n1
Standard InChI: InChI=1S/C23H37N5O2/c1-6-8-12-28(11-7-2)23-25-19-16-21(30-5)20(29-4)15-18(19)22(26-23)24-17-9-13-27(3)14-10-17/h15-17H,6-14H2,1-5H3,(H,24,25,26)
Standard InChI Key: XZUWJVJVVBARGQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 415.58 | Molecular Weight (Monoisotopic): 415.2947 | AlogP: 4.17 | #Rotatable Bonds: 10 |
Polar Surface Area: 62.75 | Molecular Species: BASE | HBA: 7 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 8.77 | CX LogP: 4.19 | CX LogD: 2.67 |
Aromatic Rings: 2 | Heavy Atoms: 30 | QED Weighted: 0.62 | Np Likeness Score: -1.02 |
1. Xiong Y, Li F, Babault N, Wu H, Dong A, Zeng H, Chen X, Arrowsmith CH, Brown PJ, Liu J, Vedadi M, Jin J.. (2017) Structure-activity relationship studies of G9a-like protein (GLP) inhibitors., 25 (16): [PMID:28662962] [10.1016/j.bmc.2017.06.021] |
Source(1):